Evaluating the Safety and Efficacy of the Indigo® Aspiration System in Acute Pulmonary Embolism

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT03218566

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
  • Penumbra Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03218566
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03218566. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-22 (actual); primary completion 2019-03-10 (actual). Results posted on 2020-08-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating the Safety and Efficacy of the Indigo® Aspiration System in Acute Pulmonary Embolism
Acronym
EXTRACT-PE
Intervention (Device)
Indigo Aspiration System
Lead sponsor
Penumbra Inc. (class: industry)

Record details

Record id
cardio:ct-nct03218566
Content hash
b52de7f4b602ed81481075d644f1977edb71df99a8645d3d72fa6d778019cd87